Which of the following agents is recommended as first line drug for treatment of gastrointestinal stromal tumors (GIST)?
High-Yield Explanation
Imatinib is drug of choice for GIST. Imatinib resistant cases can be treated with sunitinib. Tumors resistant to both imatinib and sunitinib are treated with regorafenib.